330 Combination therapy with stem cell derived natural killer cells and monoclonal antibodies leads to potent ADCC through engagement of endogenouse CD16
Anna‐Maria Georgoudaki, Jan Spanholtz(AIMM Therapeutics (Netherlands)), Denise Vodegel, Amanda van Vliet, Daniëlle Steenmans, Didem Özkazanç(Hacettepe University Hospital), Adil Deniz Duru(Marmara University), Monica Raimo(University of Turin), Nina Lamers-Kok
Cited by 0
Related Papers
Clinical-Grade Generation of Active NK Cells from Cord Blood Hematopoietic Progenitor Cells for Immunotherapy Using a Closed-System Culture Process
|PLoS ONE|2011|239
Successful Transfer of Umbilical Cord Blood CD34+ Hematopoietic Stem and Progenitor-derived NK Cells in Older Acute Myeloid Leukemia Patients
|Clinical Cancer Research|2017|211
The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments
|Frontiers in Immunology|2017|197